These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37945140)

  • 1. Downstaging Hepatocellular Carcinoma before Transplantation: Role of Immunotherapy Versus Locoregional Approaches.
    Lindemann J; Yu J; Doyle MBM
    Surg Oncol Clin N Am; 2024 Jan; 33(1):143-158. PubMed ID: 37945140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hepatocellular carcinoma.
    Said A; Wells J
    Minerva Med; 2009 Feb; 100(1):51-68. PubMed ID: 19277004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downstaging Hepatocellular Carcinoma with Checkpoint Inhibitor Therapy Improves Access to Curative Liver Transplant.
    Liu MC; Lizaola-Mayo B; Jayasekera CR; Mathur AK; Katariya N; Aqel B; Byrne TJ; Chascsa DMH
    J Gastrointest Cancer; 2024 Jun; 55(2):969-974. PubMed ID: 38483692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Locoregional Therapies in Patients With Hepatocellular Cancer Awaiting Liver Transplantation.
    Thuluvath PJ; To C; Amjad W
    Am J Gastroenterol; 2021 Jan; 116(1):57-67. PubMed ID: 33110015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma.
    Claasen MPAW; Sneiders D; Rakké YS; Adam R; Bhoori S; Cillo U; Fondevila C; Reig M; Sapisochin G; Tabrizian P; Toso C
    Transpl Int; 2023; 36():11648. PubMed ID: 37779513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioembolization for Hepatocellular Carcinoma in Downstaging and Bridging for Liver Transplantation.
    Kutlu R; Karatoprak S
    J Gastrointest Cancer; 2020 Dec; 51(4):1157-1164. PubMed ID: 32880041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
    Xing R; Gao J; Cui Q; Wang Q
    Front Immunol; 2021; 12():783236. PubMed ID: 34899747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma: systemic therapies and future perspectives.
    Mikhail S; Cosgrove D; Zeidan A
    Expert Rev Anticancer Ther; 2014 Oct; 14(10):1205-18. PubMed ID: 25199765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic treatment of advanced hepatocellular cancer: new hope on the horizon.
    Chang Lee R; Tebbutt N
    Expert Rev Anticancer Ther; 2019 Apr; 19(4):343-353. PubMed ID: 30793991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma downstaging for liver transplantation in the era of systemic combined therapy with anti-VEGF/TKI and immunotherapy.
    Tran NH; Muñoz S; Thompson S; Hallemeier CL; Bruix J
    Hepatology; 2022 Oct; 76(4):1203-1218. PubMed ID: 35765265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioembolization using yttrium-90 microspheres as bridging and downstaging treatment for unresectable hepatocellular carcinoma before liver transplantation: initial single-center experience.
    Abdelfattah MR; Al-Sebayel M; Broering D; Alsuhaibani H
    Transplant Proc; 2015 Mar; 47(2):408-11. PubMed ID: 25769582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial.
    Mazzaferro V; Citterio D; Bhoori S; Bongini M; Miceli R; De Carlis L; Colledan M; Salizzoni M; Romagnoli R; Antonelli B; Vivarelli M; Tisone G; Rossi M; Gruttadauria S; Di Sandro S; De Carlis R; Lucà MG; De Giorgio M; Mirabella S; Belli L; Fagiuoli S; Martini S; Iavarone M; Svegliati Baroni G; Angelico M; Ginanni Corradini S; Volpes R; Mariani L; Regalia E; Flores M; Droz Dit Busset M; Sposito C
    Lancet Oncol; 2020 Jul; 21(7):947-956. PubMed ID: 32615109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of living donor liver transplantation after locoregional treatment for hepatocellular carcinoma: an experience from a single institute.
    Inomata K; Yagi H; Hibi T; Shinoda M; Matsubara K; Abe Y; Kitago M; Obara H; Itano O; Kawachi S; Tanabe M; Wakabayashi G; Shimazu M; Kitagawa Y
    Surg Today; 2021 Mar; 51(3):350-357. PubMed ID: 32767130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy as a Downstaging Tool for Liver Transplantation in Hepatocellular Carcinoma.
    Lizaola-Mayo BC; Mathur AK; Borad MJ; Jadlowiec CC; Lam-Himlin DM; Corey RL; Iqbal S; Okubo K; Byrne TJ; Moss AA; Aqel BA; Chascsa DM
    Am J Gastroenterol; 2021 Dec; 116(12):2478-2480. PubMed ID: 35134013
    [No Abstract]   [Full Text] [Related]  

  • 15. Downstaging of hepatocellular carcinoma prior to liver transplant: is there a role for adjuvant sorafenib in locoregional therapy?
    Vagefi PA; Hirose R
    J Gastrointest Cancer; 2010 Dec; 41(4):217-20. PubMed ID: 20443078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Timing of Liver Transplantation Following Downstaging: Wait of Not to Wait?
    Ersan V; Barut B; Yilmaz S
    J Gastrointest Cancer; 2020 Dec; 51(4):1152-1156. PubMed ID: 32856230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.
    Llovet JM; De Baere T; Kulik L; Haber PK; Greten TF; Meyer T; Lencioni R
    Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):293-313. PubMed ID: 33510460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma downstaging in liver transplantation.
    Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
    Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New horizons in liver transplantation for hepatocellular carcinoma.
    Lindemann J; Yu J; Doyle MMB
    S Afr J Surg; 2024 May; 62(2):8-12. PubMed ID: 38838112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Section 3. Current status of downstaging of hepatocellular carcinoma before liver transplantation.
    Sharr WW; Chan SC; Lo CM
    Transplantation; 2014 Apr; 97 Suppl 8():S10-7. PubMed ID: 24849822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.